PharmD Info

A forum for Indian Pharmacy Professionals

Medicine Risk Management - Case Study

42 posts

Re: Medicine Risk Management - Case Study#2378

By Kamal Rathinam - 07 Oct 2017, 12:07

- 07 Oct 2017, 12:07 #2378

5. the most likely cause of mrs.MR's elevated INR is by anti-coagulants like warfarin
2. ciprofloxacin and warfarin causes anticoagulant control (bleeding)

Re: Medicine Risk Management - Case Study#2379

By Sherin - 05 Feb 2018, 13:25

- 05 Feb 2018, 13:25 #2379

12. for two consecutive days,alendronate(70mg) was given.
it should be given only once in a week

Page 5 of 5
42 posts

Return to “Pharmacotherapy Cases”

Jump to:

Similar Topics

Topics	Statistics	Last post
Trademark Infringement in the Pharma Industry: A Case Study of India by Admin - 13 Mar 2023, 17:28 - In: Pharmaceutical Manufacturing	0 Replies 433 Views	by Admin 13 Mar 2023, 17:28
ICH Q9 Quality Risk Management: A Practical Approach for the Pharmaceutical Industry by Admin - 10 Apr 2023, 10:47 - In: ICH-GCP Guidelines	0 Replies 1289 Views	by Admin 10 Apr 2023, 10:47
The Future of Pharmacovigilance: Predictive Analytics and Proactive Risk Management by Admin - 31 Mar 2023, 10:56 - In: Pharma Research	0 Replies 393 Views	by Admin 31 Mar 2023, 10:56
Openings for "Risk Management Plan"(RMP)-Pharmacovigilence. by Admin - 04 Jun 2021, 23:38 - In: Pharmacovigilance Jobs-Drug Safety	0 Replies 1418 Views	by Admin 04 Jun 2021, 23:38
Mucormycosis in COVID-19: modifiable risk factors and its mitigation in India by Swathi Swaroopa B - 23 Feb 2022, 15:10 - In: Pharma Journal Club	0 Replies 738 Views	by Swathi Swaroopa B 23 Feb 2022, 15:10